Article Details

Flexion Therapeutics (NASDAQ:FLXN) Stock Rating Reaffirmed by Northland Securities

Retrieved on: 2019-06-01 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

Flexion Therapeutics (NASDAQ:FLXN) Stock Rating Reaffirmed by Northland Securities. View article details on hiswai:

Excerpt

<div>Flexion Therapeutics (NASDAQ:FLXN)'s <b>stock</b> had its “buy” rating reiterated by Northland <b>Securities</b> in a research report issued to clients and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up